share_log

石藥集團：自願公告 - 根據股份獎勵計劃在市場上購買股份

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME

Hong Kong Stock Exchange ·  Apr 23 05:52
Summary by Moomoo AI
石藥集團有限公司（「石藥集團」）於2024年4月23日根據其2018年8月20日採納的限制性股份獎勵計劃，通過計劃受託人在市場上購買了合共2,934,000股股份。該批股份將以信託方式為獲選參與者持有，佔已發行股份總數約0.025%，平均每股代價約為6.012港元，總代價約17,638,940港元。購買後，受託人所持股份結餘為53,762,000股。石藥集團董事會將繼續檢討及決定未來根據計劃授予股份的數目及購買時機。
石藥集團有限公司（「石藥集團」）於2024年4月23日根據其2018年8月20日採納的限制性股份獎勵計劃，通過計劃受託人在市場上購買了合共2,934,000股股份。該批股份將以信託方式為獲選參與者持有，佔已發行股份總數約0.025%，平均每股代價約為6.012港元，總代價約17,638,940港元。購買後，受託人所持股份結餘為53,762,000股。石藥集團董事會將繼續檢討及決定未來根據計劃授予股份的數目及購買時機。
Petrol Group Limited (the “Petrol Group”) purchased a total of 2,934,000 shares on the market through its Trustees on 23 April 2024 pursuant to its Restrictive Share Award Scheme adopted on 20 August 2018. The batch of shares will be held in trust by the selected participants, representing approximately 0.025% of the issued shares at an average price of HK$6.012 per share and a total cost of approximately HK$17,638,940. After the purchase, the balance of shares held by the Trustee is 53,762,000 shares. The Board of Directors of Petrol Group will continue to review and decide on the number of shares to be granted under the plan in the future and the timing of purchases.
Petrol Group Limited (the “Petrol Group”) purchased a total of 2,934,000 shares on the market through its Trustees on 23 April 2024 pursuant to its Restrictive Share Award Scheme adopted on 20 August 2018. The batch of shares will be held in trust by the selected participants, representing approximately 0.025% of the issued shares at an average price of HK$6.012 per share and a total cost of approximately HK$17,638,940. After the purchase, the balance of shares held by the Trustee is 53,762,000 shares. The Board of Directors of Petrol Group will continue to review and decide on the number of shares to be granted under the plan in the future and the timing of purchases.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more